Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Lubetzki

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2015
Neurodegeneration in multiple sclerosis is a process separate from inflammation: YesCéline Louapre, Catherine Lubetzki
Medecine Sciences : M/S|December 29, 2009
[Monoclonal antibodies in multiple sclerosis]Caroline Papeix, Catherine Lubetzki
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2013
If I had a clinically isolated syndrome with MRI diagnostic of MS, I would take vitamin D 10,000 IU daily: NoCaroline Papeix, Catherine Lubetzki
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 27, 2016
Integrated multidisciplinary clinics should be the gold standard in managing progressive MS - NOCaroline Papeix, Catherine Lubetzki
Handbook of Clinical Neurology|February 11, 2014
Demyelination in multiple sclerosisCatherine Lubetzki, Bruno Stankoff
Trends in Neurosciences|January 22, 2003
Multiple paths towards repair in multiple sclerosisDavid Colman, Catherine Lubetzki, Stephen Reingold
Current Opinion in Neurology|May 14, 2005
Promoting repair in multiple sclerosis: problems and prospectsCatherine Lubetzki, Anna Williams, Bruno Stankoff
Glia|July 13, 2007
Astrocytes--friends or foes in multiple sclerosis?Anna Williams, Gabrièle Piaton, Catherine Lubetzki
Journal of Neurochemistry|June 8, 2010
Axon-oligodendrocyte interactions during developmental myelination, demyelination and repairGabrièle Piaton, Robert M Gould, Catherine Lubetzki
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2012
Changes at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology?Anne Desmazières, Nathalie Sol-Foulon, Catherine Lubetzki
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2015
Neurodegeneration in multiple sclerosis is a process separate from inflammation: YesCéline Louapre, Catherine Lubetzki
Medecine Sciences : M/S|December 29, 2009
[Monoclonal antibodies in multiple sclerosis]Caroline Papeix, Catherine Lubetzki
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2013
If I had a clinically isolated syndrome with MRI diagnostic of MS, I would take vitamin D 10,000 IU daily: NoCaroline Papeix, Catherine Lubetzki
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 27, 2016
Integrated multidisciplinary clinics should be the gold standard in managing progressive MS - NOCaroline Papeix, Catherine Lubetzki
Handbook of Clinical Neurology|February 11, 2014
Demyelination in multiple sclerosisCatherine Lubetzki, Bruno Stankoff
Trends in Neurosciences|January 22, 2003
Multiple paths towards repair in multiple sclerosisDavid Colman, Catherine Lubetzki, Stephen Reingold
Current Opinion in Neurology|May 14, 2005
Promoting repair in multiple sclerosis: problems and prospectsCatherine Lubetzki, Anna Williams, Bruno Stankoff
Glia|July 13, 2007
Astrocytes--friends or foes in multiple sclerosis?Anna Williams, Gabrièle Piaton, Catherine Lubetzki
Journal of Neurochemistry|June 8, 2010
Axon-oligodendrocyte interactions during developmental myelination, demyelination and repairGabrièle Piaton, Robert M Gould, Catherine Lubetzki
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2012
Changes at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology?Anne Desmazières, Nathalie Sol-Foulon, Catherine Lubetzki
Pageof 14